Millipore Sigma Vibrant Logo

341608 FGF Receptor Tyrosine Kinase Inhibitor - CAS 192705-79-6 - Calbiochem

概述

Replacement Information

重要规格表

CAS #Empirical Formula
192705-79-6C₂₀H₂₄N₆O₃

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
341608-5MGCN
正在查询供货情况......
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      塑胶安瓿;塑胶针药瓶 5 mg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      Request Pricing
      Description
      OverviewA cell-permeable pyridopyrimidinyl urea compound that acts a potent, ATP-competitive inhibitor of FGFR (IC50 = 60 nM using FGFR1) with excellent selectivity over PDGFRβ, EGFR, insulin receptor, and c-Src (IC50 > 50 µM).
      Catalogue Number341608
      Brand Family Calbiochem®
      SynonymsPD 166866, 1-(2-Amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)-3-tert-butyl urea
      References
      ReferencesPanek, R.L., et al. 1998. J. Pharm. Exp. Ther. 286, 569.
      Hamby, J.M., et al. 1997. J. Med. Chem. 40, 2296.
      Product Information
      CAS number192705-79-6
      FormOff-white solid
      Hill FormulaC₂₀H₂₄N₆O₃
      Chemical formulaC₂₀H₂₄N₆O₃
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38

      Irritating to eyes, respiratory system and skin.
      S PhraseS: 26-36-45

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      341608-5MGCN 04055977195217

      Documentation

      FGF Receptor Tyrosine Kinase Inhibitor - CAS 192705-79-6 - Calbiochem MSDS

      职位

      物料安全数据表 (MSDS) 

      FGF Receptor Tyrosine Kinase Inhibitor - CAS 192705-79-6 - Calbiochem 分析证书

      标题批号
      341608

      参考

      参考信息概述
      Panek, R.L., et al. 1998. J. Pharm. Exp. Ther. 286, 569.
      Hamby, J.M., et al. 1997. J. Med. Chem. 40, 2296.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-April-2011 RFH
      SynonymsPD 166866, 1-(2-Amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)-3-tert-butyl urea
      DescriptionA cell-permeable pyridopyrimidinyl urea compound that acts a potent, ATP-competitive inhibitor of FGFR (IC50 = 60 nM using FGFR1) with excellent selectivity over PDGFRβ, EGFR, insulin receptor, and c-Src (IC50 > 50 µM).
      FormOff-white solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number192705-79-6
      Chemical formulaC₂₀H₂₄N₆O₃
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Irritant
      ReferencesPanek, R.L., et al. 1998. J. Pharm. Exp. Ther. 286, 569.
      Hamby, J.M., et al. 1997. J. Med. Chem. 40, 2296.